[Beta-blockade--a new therapeutic modality in chronic heart insufficiency]. / Betablokade--en ny behandlingsmodalitet ved kronisk hjerteinsufficiens.
Ugeskr Laeger
; 161(37): 5152-5, 1999 Sep 13.
Article
de Da
| MEDLINE
| ID: mdl-10523946
ABSTRACT
Heart failure due to decreased left ventricular function is a condition with a considerable morbidity and mortality. Until recently beta-blocker treatment has been considered contraindicated in this condition. During the last 20 years a number of investigations have pointed to a possible positive effect of beta-blocker treatment in chronic heart failure and recently several major randomized trials have shown a significantly increased survival during beta-blocker treatment. This review summarizes the background for the use of beta-blocker treatment in chronic heart failure patients.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Antagonistes bêta-adrénergiques
/
Défaillance cardiaque
Type d'étude:
Clinical_trials
Limites:
Humans
Langue:
Da
Journal:
Ugeskr Laeger
Année:
1999
Type de document:
Article